Found: 10
Select item for more details and to access through your institution.
Development of Acute Adult T-cell Leukemia Following PD-1 Blockade Therapy for Lung Cancer.
- Published in:
- Internal Medicine, 2022, v. 61, n. 22, p. 3421, doi. 10.2169/internalmedicine.9405-22
- By:
- Publication type:
- Article
Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR- ABL1 transcripts by imatinib therapy.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 972, doi. 10.1007/s10147-017-1141-y
- By:
- Publication type:
- Article
Further Characterization of CD34-Low/Negative Mouse Hematopoietic Stem Cells.
- Published in:
- Annals of the New York Academy of Sciences, 1999, v. 872, n. 1, p. 57, doi. 10.1111/j.1749-6632.1999.tb08453.x
- By:
- Publication type:
- Article
Acute promyelocytic leukemia presenting as recurrent spinal myeloid sarcomas 3 years before developing leukemia: A case report with review of literature.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 2, p. 316, doi. 10.1002/ccr3.1991
- By:
- Publication type:
- Article
Myelodysplastic hematopoiesis mimicking the bone marrow in a mediastinal myelolipoma.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 4, p. 385, doi. 10.1002/ccr3.777
- By:
- Publication type:
- Article
Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 12, p. 938, doi. 10.1002/ajh.21284
- By:
- Publication type:
- Article
Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.
- Published in:
- Acta Haematologica, 2019, v. 141, n. 2, p. 111, doi. 10.1159/000495338
- By:
- Publication type:
- Article
Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission.
- Published in:
- Cancer Science, 2020, v. 111, n. 8, p. 2923, doi. 10.1111/cas.14518
- By:
- Publication type:
- Article
Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 182, doi. 10.1111/cas.13430
- By:
- Publication type:
- Article
Adult paroxysmal cold hemoglobinuria following mRNA COVID‐19 vaccination.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 992, doi. 10.1002/jha2.508
- By:
- Publication type:
- Article